{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05640102",
            "orgStudyIdInfo": {
                "id": "BGB-3111-402"
            },
            "organization": {
                "fullName": "BeiGene",
                "class": "INDUSTRY"
            },
            "briefTitle": "Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenstr\u00f6m Macroglobulinemia",
            "officialTitle": "A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Patients With Waldenstr\u00f6m Macroglobulinemia",
            "therapeuticArea": [
                "Other"
            ],
            "study": "observational-study-evaluating-the-efficacy-and-safety-of-zanubrutinib-in-participants-with-macroglobulinemia"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-11-28",
            "studyFirstSubmitQcDate": "2022-11-28",
            "studyFirstPostDateStruct": {
                "date": "2022-12-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "BeiGene",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This is a hybrid (retrospective and prospective) non-interventional registry study to further describe the clinical profile of zanubrutinib in Waldenstr\u00f6m macroglobulinemia (WM) participants with and without specific mutations and from racial and ethnic minority groups. Data collected from this registry study will be used to better understand the clinical benefit and safety of zanubrutinib for the treatment of participants in these populations."
        },
        "conditionsModule": {
            "conditions": [
                "Waldenstrom Macroglobulinemia"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": true,
            "targetDuration": "5 Years",
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "OTHER"
            },
            "enrollmentInfo": {
                "count": 111,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1: MYD88 L265P mutation",
                    "description": "Arm A: Treatment-na\u00efve (TN); Arm B: Relapsed/refractory (R/R)",
                    "interventionNames": [
                        "Drug: Zanubrutinib"
                    ]
                },
                {
                    "label": "Cohort 2: Non-L265P MYD88 mutation(s) and MYD88 wildtype",
                    "description": "Arm C: TN and R/R",
                    "interventionNames": [
                        "Drug: Zanubrutinib"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Zanubrutinib",
                    "description": "Dosing and treatment duration are at the discretion of the prescribing physician and in accordance with local labeling",
                    "armGroupLabels": [
                        "Cohort 1: MYD88 L265P mutation",
                        "Cohort 2: Non-L265P MYD88 mutation(s) and MYD88 wildtype"
                    ],
                    "otherNames": [
                        "BGB-3111",
                        "Brukinsa"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Major Response Rate (MRR)",
                    "description": "MRR is defined as the proportion of participants achieving either complete response (CR), very good partial response (VGPR), or partial response (PR) as determined by the investigator using an adaptation of the response criteria updated at the Sixth International Workshop on WM (IWWM)",
                    "timeFrame": "Up to approximately 4 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "VGPR+ Rate",
                    "description": "VGPR+ rate is defined as the proportion of participants achieving either CR or VGPR",
                    "timeFrame": "Up to approximately 5 years"
                },
                {
                    "measure": "Overall Response Rate (ORR)",
                    "description": "ORR is defined as the proportion of participants achieving either CR, VGPR, PR, or minor response (MR)",
                    "timeFrame": "Up to approximately 5 years"
                },
                {
                    "measure": "Duration of Response (DOR)",
                    "description": "DOR is defined as the time from the first determination of response (CR, VGPR, or PR) until first documentation of or death, whichever comes first",
                    "timeFrame": "Up to approximately 5 years"
                },
                {
                    "measure": "Number of Participants with Treatment-emergent Adverse Events",
                    "timeFrame": "Up to approximately 5 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Clinical and definitive histologic diagnosis of WM\n* Measurable disease, as defined by a serum immunoglobulin M (IgM) level \\> 0.5 g/dL at the time of zanubrutinib initiation\n* Started treatment with zanubrutinib, has been treated with zanubrutinib, or is planned to be prescribed zanubrutinib for the treatment of WM\n* Bone marrow specimens with central MYD88 test results of:\n\n  1. Cohort 1: MYD88 L265P mutation; enrollment of TN participants will be stopped in each racial and ethnic participant group when the required numbers of participants in the group are met\n  2. Cohort 2: non-L265P MYD88 mutation(s) and MYD88WT\n\nExclusion Criteria:\n\n* Evidence of disease transformation before the first dose of zanubrutinib\n* Evidence of other non-Hodgkin Lymphoma (NHL) subtypes\n* Prior or concurrent active malignancy \u2264 2 years before the first dose of zanubrutinib, except for malignancies that, in the investigator's opinion, will not obscure the interpretation of safety or efficacy results\n* Concurrent participation in another therapeutic clinical study while receiving zanubrutinib, although the participant may be eligible depending on the status of the interventional study after discussion with the Medical Monitor or designee on an individual basis",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Adult participants with WM who are either already receiving or are planned to start treatment with zanubrutinib",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Study Director",
                    "role": "CONTACT",
                    "phone": "1-877-828-5568",
                    "email": "clinicaltrials@beigene.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Study Director",
                    "affiliation": "BeiGene",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mitchell Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Mobile",
                    "state": "Alabama",
                    "zip": "36604",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.69436,
                        "lon": -88.04305
                    }
                },
                {
                    "facility": "City of Hope National Medical Center",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Valkyrie Clinical Trials",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90067",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Eisenhower Medical Center, Lucy Curci Cancer Center",
                    "status": "RECRUITING",
                    "city": "Rancho Mirage",
                    "state": "California",
                    "zip": "92270",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.73974,
                        "lon": -116.41279
                    }
                },
                {
                    "facility": "Pacific Central Coast Health Centers, Slo Oncology and Hematology Health Center",
                    "status": "RECRUITING",
                    "city": "San Luis Obispo",
                    "state": "California",
                    "zip": "93401",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.28275,
                        "lon": -120.65962
                    }
                },
                {
                    "facility": "Pacific Central Coast Health Centers, Mission Hope Medical Oncology",
                    "status": "RECRUITING",
                    "city": "Santa Maria",
                    "state": "California",
                    "zip": "93454",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.95303,
                        "lon": -120.43572
                    }
                },
                {
                    "facility": "Brcr Medical Center, Inc",
                    "status": "RECRUITING",
                    "city": "Plantation",
                    "state": "Florida",
                    "zip": "33322",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.13421,
                        "lon": -80.23184
                    }
                },
                {
                    "facility": "Tulane Cancer Center",
                    "status": "RECRUITING",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70112",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                },
                {
                    "facility": "Hattiesburg Hematology and Oncology Clinic",
                    "status": "RECRUITING",
                    "city": "Hattiesburg",
                    "state": "Mississippi",
                    "zip": "39401",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 31.32712,
                        "lon": -89.29034
                    }
                },
                {
                    "facility": "Comprehensive Cancer Centers of Nevada",
                    "status": "RECRUITING",
                    "city": "Las Vegas",
                    "state": "Nevada",
                    "zip": "89169",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.17497,
                        "lon": -115.13722
                    }
                },
                {
                    "facility": "Summit Medical Group",
                    "status": "RECRUITING",
                    "city": "Florham Park",
                    "state": "New Jersey",
                    "zip": "07932",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.78788,
                        "lon": -74.38821
                    }
                },
                {
                    "facility": "Morristown Medical Center",
                    "status": "RECRUITING",
                    "city": "Morristown",
                    "state": "New Jersey",
                    "zip": "07960",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.79677,
                        "lon": -74.48154
                    }
                },
                {
                    "facility": "Clinical Research Alliance, Inc",
                    "status": "RECRUITING",
                    "city": "Westbury",
                    "state": "New York",
                    "zip": "11590",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.75566,
                        "lon": -73.58763
                    }
                },
                {
                    "facility": "Pan American Oncology Trials, Llc",
                    "status": "RECRUITING",
                    "city": "Rio Piedras",
                    "zip": "00935",
                    "country": "Puerto Rico",
                    "geoPoint": {
                        "lat": 18.39745,
                        "lon": -66.04989
                    }
                },
                {
                    "facility": "Auxilio Mutuo Cancer Center",
                    "status": "RECRUITING",
                    "city": "San Juan",
                    "zip": "00917",
                    "country": "Puerto Rico",
                    "geoPoint": {
                        "lat": 18.46633,
                        "lon": -66.10572
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008258",
                    "term": "Waldenstrom Macroglobulinemia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000054219",
                    "term": "Neoplasms, Plasma Cell"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000020141",
                    "term": "Hemostatic Disorders"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000010265",
                    "term": "Paraproteinemias"
                },
                {
                    "id": "D000001796",
                    "term": "Blood Protein Disorders"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000006474",
                    "term": "Hemorrhagic Disorders"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11251",
                    "name": "Waldenstrom Macroglobulinemia",
                    "asFound": "Waldenstrom Macroglobulinemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27588",
                    "name": "Neoplasms, Plasma Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M21977",
                    "name": "Hemostatic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5059",
                    "name": "Blood Coagulation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13178",
                    "name": "Paraproteinemias",
                    "relevance": "LOW"
                },
                {
                    "id": "M5077",
                    "name": "Blood Protein Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9560",
                    "name": "Hemorrhagic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5887",
                    "name": "Waldenstrom Macroglobulinemia",
                    "asFound": "Waldenstrom Macroglobulinemia",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000629551",
                    "term": "Zanubrutinib"
                }
            ],
            "ancestors": [
                {
                    "id": "D000092004",
                    "term": "Tyrosine Kinase Inhibitors"
                },
                {
                    "id": "D000047428",
                    "term": "Protein Kinase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M42199",
                    "name": "Zanubrutinib",
                    "asFound": "Flavor",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2889",
                    "name": "Tyrosine Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M25820",
                    "name": "Protein Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T22",
                    "name": "Tyrosine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}